These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 2670511)

  • 21. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
    Titmarsh S; Monk JP
    Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond.
    Kirchengast M
    J Hypertens Suppl; 1997 Mar; 15(2):S27-33. PubMed ID: 9218195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
    Bakris GL; Cooper-Dehoff RM; Zhou Q; Kupfer S; Champion A; Pepine CJ;
    Am J Cardiovasc Drugs; 2007; 7 Suppl 1():25-9. PubMed ID: 19845074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical use of calcium antagonists in hypertension: update 1986.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S29-35. PubMed ID: 2455135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
    Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic and pharmacodynamic properties and therapeutic use of bunazosin in hypertension. A review.
    Weidinger G
    Arzneimittelforschung; 1995 Nov; 45(11):1166-71. PubMed ID: 8929232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive therapy in the aged patient. Clinical pharmacokinetic considerations.
    Piepho RW; Fendler KJ
    Drugs Aging; 1991 May; 1(3):194-211. PubMed ID: 1686570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Verapamil revisited: a transition in novel drug delivery systems and outcomes.
    Prisant LM
    Heart Dis; 2001; 3(1):55-62. PubMed ID: 11975770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trandolapril/verapamil sustained release: a review of its use in the treatment of essential hypertension.
    Reynolds NA; Wagstaff AJ; Keam SJ
    Drugs; 2005; 65(13):1893-914. PubMed ID: 16114984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cadralazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.
    McTavish D; Young RA; Clissold SP
    Drugs; 1990 Oct; 40(4):543-60. PubMed ID: 2083513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lercanidipine : a review of its efficacy in the management of hypertension.
    Bang LM; Chapman TM; Goa KL
    Drugs; 2003; 63(22):2449-72. PubMed ID: 14609358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.
    Saltiel E; Ellrodt AG; Monk JP; Langley MS
    Drugs; 1988 Oct; 36(4):387-428. PubMed ID: 3069435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adult hypertension: reducing cardiovascular morbidity and mortality.
    Prescrire Int; 2005 Feb; 14(75):25-33. PubMed ID: 15751180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of verapamil in the treatment of hypertension.
    Anavekar SN; Doyle AE
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):90S-99S. PubMed ID: 3540229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.